September/October 2004

 

In this Issue

Glaucoma Today

Issue

Lifestyle Changes and Glaucoma

Counseling patients on how these alterations may affect glaucomatous disease.

By Robert J. Noecker, MD

The New Glaucoma Surgeries

Nonpenetrating surgery and novel, investigational, Schlemm’s canal shunting devices reduce dependence on the healing whims of the conjunctiva.

By Thomas W. Samuelson, MD

The Uniocular Trial Myth

Debunking the dogma underlying the monocular drug trial.

By Tony Realini, MD

Koniocellular Pathway Damage in Glaucoma

Ocular hypertension affects the blue/yellow neurons.

By Yeni H. Yücel, MD, PhD; Robert N. Weinreb, MD; Paul L. Kaufman, MD; and Neeru Gupta, MD, PhD

Sturge-Weber Syndrome and Glaucoma

By Lisa A. Herrygers, MD

5 Questions With David L. Epstein, MD

By David L. Epstein, MD

An Evaluation of Ultrasonic Pachymeters

Assistance in selecting a unit.

By Leon W. Herndon, MD

Pericardial Patch Melting

A complication of drainage device surgery.

By Marlene R. Moster, MD; Jeffrey D. Henderer, MD; and Augusto Azuara-Blanco, MD, PhD, FRCSEd
 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.